Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs EXEL✓SelectedUSD · EXELGSK vs EXEL performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs EXEL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+55.4%
EXEL return
+222.9%
Excess return
-167.5%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioEXELExcessAlpha
1D-1.3%-0.3%-1.0%-1.3%
7D-3.1%-3.4%+0.3%-2.7%
30D-0.9%+9.0%-9.8%-1.9%
3M-4.2%+28.6%-32.7%-6.9%
6M-1.6%+37.0%-38.6%-5.0%
YTD+2.6%+55.8%-53.2%-2.4%
1Y+6.2%+60.1%-53.9%+0.8%
All+55.4%+222.9%-167.5%+41.9%

Cumulative growth

Daily Returns

Daily percentage return beside EXEL.

Daily Out/Under-Performance

Portfolio return minus EXEL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EXEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded EXEL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling